Related Experiment Video
Updated: Jun 3, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Clinical Risks and Underlying Mechanisms of Atrial Fibrillation after Myocardial Infarction
Tian-Peng Wei1, Xiao-Lu Zhang1, Wen-Rui Wang1
1Department of Cardiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China.
Abstract:
Atrial Fibrillation (AF) following Myocardial Infarction (MI) is a common clinical complication that significantly impairs patient prognosis and quality of life. This review examines the clinical risks and underlying pathophysiological mechanisms of post-MI AF. The pathophysiology of AF after MI involves multiple maladaptive processes, particularly atrial structural and electrical remodeling, which collectively establish the arrhythmogenic substrate. This review summarizes the molecular mechanisms contributing to AF in the post-infarction setting. Furthermore, it was synthesized current evidence on pharmacological interventions targeting this substrate, highlighting four primary mechanisms of action: anti-fibrotic effects, modulation of calcium homeostasis, endogenous hormone regulation, and anti-inflammatory actions. Consequently, elucidating the complex and dynamic pathophysiological changes that drive atrial fibrillation after myocardial infarction may inform the development of targeted therapeutic strategies for post-infarction AF.
Insights
Atrial Fibrillation (AF) after Myocardial Infarction (MI) involves complex remodeling. Understanding these mechanisms can guide new treatments for post-MI AF.
Area of Science:
- Cardiology
- Electrophysiology
- Pathophysiology
Background:
- Atrial Fibrillation (AF) is a frequent complication post-Myocardial Infarction (MI), worsening patient outcomes.
- The development of AF post-MI is linked to significant atrial structural and electrical changes.
Purpose of the Study:
- To review the clinical risks and pathophysiological mechanisms of AF following MI.
- To summarize molecular pathways driving AF in the post-infarction state.
- To synthesize evidence on pharmacological interventions targeting AF post-MI.
Main Methods:
- Literature review of clinical risks and pathophysiological mechanisms.
- Analysis of molecular mechanisms contributing to AF post-MI.
- Synthesis of current evidence on pharmacological interventions.
Main Results:
- Post-MI AF involves maladaptive processes, including atrial remodeling, creating an arrhythmogenic substrate.
- Key molecular mechanisms contributing to AF in this setting were identified.
- Pharmacological interventions target anti-fibrotic effects, calcium homeostasis, hormone regulation, and inflammation.
Conclusions:
- Elucidating the dynamic pathophysiological changes in post-MI AF is crucial.
- Targeted therapeutic strategies for post-infarction AF can be developed based on these insights.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Mechanism of Cardiac Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Coronary Artery Disease III: Clinical Manifestations
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Rheumatic Heart Disease I: Introduction

